Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

survival

  • Open Access
    Prognostic Factors for Patients With Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy Followed by Surgery
    NAO KITASAKI, YOICHI HAMAI, MANABU EMI, TOMOAKI KUROKAWA, TORU YOSHIKAWA, RYOSUKE HIROHATA, MANATO OHSAWA and MORIHITO OKADA
    In Vivo November 2022, 36 (6) 2852-2860; DOI: https://doi.org/10.21873/invivo.13025
  • Open Access
    Survival Analysis Using the Covid-death Mean-imputation (CoDMI) Algorithm: A First Clinical Application in Radiation Oncology
    FRANCESCA DE FELICE, LUCA MAZZONI, DANIELA MUSIO, VINCENZO TOMBOLINI and FRANCO MORICONI
    In Vivo November 2022, 36 (6) 2986-2992; DOI: https://doi.org/10.21873/invivo.13043
  • Open Access
    The Clinical Impact of Synchronous and Metachronous Other Primary Cancer in Gastric Cancer Patients Who Receive Curative Treatment
    TORU AOYAMA, MIWHA JU, KEISUKE KOMORI, HIROSHI TAMAGAWA, AYAKO TAMAGAWA, YUKIO MAEZAWA, ITARU HASHIMOTO, KAZUKI KANO, KENTARO HARA, HARUHIKO CHO, JUNYA MORITA, KENKI SEGAMI, ATSUSHI ONODERA, KAZUYA ENDO, SHIZUNE ONUMA, TAKASHI OSHIMA, NORIO YUKAWA and YASUSHI RINO
    In Vivo September 2022, 36 (5) 2514-2520; DOI: https://doi.org/10.21873/invivo.12987
  • Open Access
    Tumor Budding as a Predictive Marker of Relapse and Survival in Patients With Stage II Colon Cancer
    KAZUYUKI SAITO, TAKASHI OKUYAMA, SHUNYA MIYAZAKI, HARUKA OI, TAKASHI MITSUI, TAKUJI NORO, EMIKO TAKESHITA, YUKO ONO, TAIZEN URAHASHI, HIDEHIRO TAJIMA and HIDEYUKI YOSHITOMI
    In Vivo July 2022, 36 (4) 1820-1828; DOI: https://doi.org/10.21873/invivo.12898
  • Open Access
    The Platelet-to-Lymphocyte Ratio Is an Independent Prognostic Factor for Patients With Esophageal Cancer Who Receive Curative Treatment
    TORU AOYAMA, MIWA JU, KEISUKE KOMORI, HIROSHI TAMAGAWA, AYAKO TAMAGAWA, ATSUSHI ONODERA, JUNYA MORITA, ITARU HASHIMOTO, TETSUSHI ISHIGURO, KAZUYA ENDO, HARUHIKO CHO, SHIZUΝE ONUMA, MOMOKO FUKUDA, TAKASHI OSHIMA, NORIO YUKAWA and YASUSHI RINO
    In Vivo July 2022, 36 (4) 1916-1922; DOI: https://doi.org/10.21873/invivo.12912
  • Open Access
    Clinical Impact of Preoperative Albumin-Bilirubin Status in Esophageal Cancer Patients Who Receive Curative Treatment
    TORU AOYAMA, MIHWA JU, DAISUKE MACHIDA, KEISUKE KOMORI, HIROSHI TAMAGAWA, AYAKO TAMAGAWA, YUKIO MAEZAWA, KAZUKI KANO, KENTARO HARA, KENKI SEGAMI, ITARU HASHIMOTO, SHINSUKE NAGASAWA, MASATO NAKAZONO, TAKASHI OSHIMA, NORIO YUKAWA and YASUSHI RINO
    In Vivo May 2022, 36 (3) 1424-1431; DOI: https://doi.org/10.21873/invivo.12847
  • Open Access
    Prognostic Factors of Survival After Radiotherapy for Lung Cancer–The Impact of Smoking Pack Years
    ELISA M. WERNER, ESTHER GLATZEL, SABINE BOHNET, STEVEN E. SCHILD and DIRK RADES
    In Vivo May 2022, 36 (3) 1297-1301; DOI: https://doi.org/10.21873/invivo.12830
  • You have access
    The Clinical Influence of the CONUT Score on Survival of Patients With Gastric Cancer Receiving Curative Treatment
    TORU AOYAMA, KEISUKE KOMORI, MASATO NAKAZANO, KENTARO HARA, HIROSHI TAMAGAWA, KEISUKE KAZAMA, ITARU HASHIMOTO, TAKANOBU YAMADA, YUKIO MAEZAWA, KENKI SEGAMI, KAZUKI KANO, SHINSUKE NAGASAWA, NORIO YUKAWA, YASUSHI RINO, TAKASHI OGATA and TAKASHI OSHIMA
    In Vivo March 2022, 36 (2) 942-948; DOI: https://doi.org/10.21873/invivo.12784
  • You have access
    The Clinical Influence of the C-Reactive Protein-to-Albumin Ratio in Patients Who Received Curative Treatment for Gastric Cancer
    TORU AOYAMA, MASATO NAKAZONO, KENKI SEGAMI, SHINSUKE NAGASAWA, KAZUKI KANO, TAKANOBU YAMADA, YUKIO MAEZAWA, KENTARO HARA, ITARU HASHIMOTO, HIDEAKI SUEMATSU, HAYATO WATANABE, KOSUKE TAKAHASHI, MASAKATSU NUMATA, HIROSHI TAMAGAWA, NORIO YUKAWA, YASUSHI RINO, TAKASHI OGATA and TAKASHI OSHIMA
    In Vivo November 2021, 35 (6) 3475-3482; DOI: https://doi.org/10.21873/invivo.12648
  • You have access
    Impact of Intraoperative Blood Loss on the Survival of Patients With Stage II/III Colorectal Cancer: A Multicenter Retrospective Study
    HIROSHI TAMAGAWA, MASAKATSU NUMATA, TORU AOYAMA, KEISUKE KAZAMA, YOSUKE ATSUMI, KENTA IGUCHI, SHO SAWAZAKI, SUMITO SATO, KAZUKI KANO, TAKASHI OHSHIMA, TAKANOBU YAMADA, TENI GODAI, AKIO HIGUCHI, HIROYUKI SAEKI, NORIO YUKAWA and YASUSHI RINO
    In Vivo November 2021, 35 (6) 3483-3488; DOI: https://doi.org/10.21873/invivo.12649

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
In Vivo

© 2025 In Vivo

Powered by HighWire